Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System.

Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System. Cardiovasc Drugs Ther. 2021 06; 35(3):533-538.

View in: PubMed

subject areas

Age Factors
Aged
Aged, 80 and over
Aspirin
Atherosclerosis
Budgets
Cardiovascular Diseases
Cigarette Smoking
Cross-Sectional Studies
Diabetes Mellitus
Dose-Response Relationship, Drug
Drug Therapy, Combination
Factor Xa Inhibitors
Female
Health Expenditures
Hemorrhage
Humans
Male
Middle Aged
Peripheral Arterial Disease
Renal Insufficiency, Chronic
Rivaroxaban
United States
United States Department of Veterans Affairs

authors with profiles

CHRISTIE BALLANTYNE
LAURA PETERSEN
SALIM VIRANI